scorecard

You Searched For "biocon" and got 17 results


Sort By:


Business Insider Latest Story Image
2 mins read

Biocon’s subsidiary raises $30 million from Tata Capital – company’s shares jump by almost 2%

Biocon’s subsidiary company Biocon Biologics has raised $30 million from Tata Capital Growth Fund, …

Business Insider Latest Story Image
1 min read

Biocon Q1FY23 revenue up 23% at Rs 2,217 cr

Global biopharmaceuticals company Biocon on Wednesday reported 23 per cent rise in revenue for the …

Business Insider Latest Story Image
2 mins read

Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion

In addition to vaccines, the strategic alliance will also develop antibodies targeting seve…

PTI   


Business Insider Latest Story Image
2 mins read

Biocon Brings Dr Vijay Kuchroo And Dr Jeremy Levin On Board

Currently, Dr Kuchroo is the Samuel L Wasserstrom professor of Neurology at Harvard Medical School,…

Business Insider Latest Story Image
2 mins read

True North to invest Rs 536.25 crore in Biocon Biologics for 2.44 pc stake

New Delhi, Jan 6 () Biotechnology major Biocon on Monday said private equity firm True North will i…

PTI   


Business Insider Latest Story Image
3 mins read

Biocon’s Kiran Mazumdar Shaw, who debuted in the pharma industry with two employees and $500 becomes EY World Entrepreneur of the Year 2020

With this, she has joined the likes of Uday Kotak of Kotak Mahindra Bank and Narayana Murthy of …

Business Insider Latest Story Image
1 min read

Biocon shares rally nearly 8 pc after Q4 earnings

New Delhi, May 24 (PTI) Shares of Biocon climbed nearly 8 per cent on Wednesday after the biotechno…

PTI   


Business Insider Latest Story Image
1 min read

Biocon, Equillium expand licensing pact for Itolizumab to include Australia, New Zealand

New Delhi, Dec 12 () Biotechnology major Biocon and US-based biotechnology firm Equillium Inc on Th…

PTI   


Business Insider Latest Story Image
1 min read

Biocon, Mylan get USFDA nod for pegfilgrastim drug substance licence

New Delhi, Nov 27 () Biotechnology major Biocon on Wednesday said that US health regulator has appr…

PTI   


Business Insider Latest Story Image
2 mins read

Biocon to launch drug for COVID-19 patients at ₹ 8,000 per vial

Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatme…

PTI   


Business Insider Latest Story Image
1 min read

Biocon, Mylan win patent litigation against Sanofi in US for insulin glargine device

"In October 2017, Sanofi had initiated patent infringement litigation against our NDA in the US Di…

PTI   


Business Insider Latest Story Image
1 min read

Biocon gets 3 USFDA observations for insulin facility in Malaysia

As per the USFDA, Form 483 is issued to firm management at the conclusion of an inspection when in…

PTI   


Business Insider Latest Story Image
1 min read

Biocon gets DCGI nod for use of Itolizumab for treatment of COVID-19 patients

"As an innovation-led biopharmaceuticals company, I am proud of the successful outcome of the pivo…

PTI   


Business Insider Latest Story Image
1 min read

Biocon gets two observations from USFDA for Bengaluru-based API plant

The US Food and Drug Administration (USFDA) had conducted a post approval and GMP inspection of co…

PTI   


Business Insider Latest Story Image
1 min read

Biocon gets EIR from USFDA for manufacturing facility in Bengaluru

"Biocon has received the EIR from the US Food and Drug Administration (FDA) for the post-approval …

PTI   


Business Insider Latest Story Image
3 mins read

Biocon shares are depressed itself but Syngene can offer a shot of hope

The Bengaluru-based biopharmaceutical company Biocon Limited share price fell over 3%. Investors …